Abstract
Studies investigating whether adults have diminished survival from medulloblastoma (MB) compared with children have yielded conflicting results. We sought to determine in a population-based registry whether adults and children with MB differ in survival, and to examine whether dissimilar use of chemotherapy might contribute to any disparity. 1,226 MB subjects were identified using the Surveillance Epidemiology and End Results (SEER-9) registry (1973–2002) and survival analysis performed. MB was defined strictly to exclude non-cerebellar primitive neuro-ectodermal tumors. Patients were stratified by age at diagnosis: <3 years (infants), 3–17 years (children) and ≥18 years (adults). Because the SEER-9 registry lacks treatment data, a subset of 142 patients were identified using the San Francisco-Oakland SEER registry (1988–2003) and additional analyses performed. There was no significant difference in survival between children and adults with MB in either the SEER-9 (P = 0.17) or SFO (P = 0.89) cohorts but infants fared worse compared to both children (P < 0.01) and adults (P < 0.01). In the SFO sample, children and adults who received chemotherapy plus radiation therapy (XRT) did not differ in survival. Among patients treated with XRT alone, children showed increased survival (P = 0.04) compared with adults. Children and adults with MB do not differ with respect to overall survival, yet infants fare significantly worse. For children and adults with MB treated with both XRT and chemotherapy, we could not demonstrate a survival difference. Similar outcomes between adult and childhood MB may justify inclusion of adults in pediatric cooperative trials for MB.
Similar content being viewed by others
References
Roberts RO, Lynch CF, Jones MP, Hart MN (1991) Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol 50:134–144. doi:10.1097/00005072-199103000-00005
Duffner PK, Cohen ME, Myers MH, Heise HW (1986) Survival of children with brain tumors: SEER Program 1973–1980. Neurology 36:597–601
Lai R (2008) Survival of patients with adult medulloblastoma: a population-based study. Cancer 112:1568–1574. doi:10.1002/cncr.23329
Le QT, Weil MD, Wara WM et al (1997) Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am 3:238–245
Peterson K, Walker RW (1995) Medulloblastoma/primitive neuroectodermal tumor in 45 adults. Neurology 45:440–442
Prados MD, Warnick RE, Wara WM et al (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32:1145–1152. doi:10.1016/0360-3016(94)00476-2
Greenberg HS, Chamberlain MC, Glantz MJ, Wang S (2001) Adult medulloblastoma: multiagent chemotherapy. Neurooncology 3:29–34. doi:10.1215/15228517-3-1-29
Padovani L, Sunyach MP, Perol D et al (2007) Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 68:433–440. doi:10.1016/j.ijrobp.2006.12.030
Brandes AA, Franceschi E, Tosoni A et al (2007) Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110:2035–2041. doi:10.1002/cncr.23003
Duffner PK, Horowitz ME, Krischer JP et al (1993) Postoperative chemotherapy and delayed radiation in children les than three years of age with malignant brain tumors. N Engl J Med 328:1725–1731. doi:10.1056/NEJM199306173282401
Evans AE, Jenkin RD, Sposto R et al (1990) The treatment of medulloblastoma, results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572–582
Packer RJ, Sutton LN, Goldwein JW et al (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433–440
Packer RJ, Sutton LN, Elterman R (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698
Pomeroy SL, Tamayo P, Gaasenbeek M et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442. doi:10.1038/415436a
Cress RD, Zaslavsky AM, West DW (2003) Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 41:1006–1012. doi:10.1097/01.MLR.0000083740.12949.88
CBTRUS (2005) Statistical report: primary brain tumors in the United States, 1998–2002. Published by the Central Brain Tumor Registry of the United States
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Curran was supported by the Stanford University Medical Scholars Program and the Child Neurology Foundation.
Rights and permissions
About this article
Cite this article
Curran, E.K., Le, G.M., Sainani, K.L. et al. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. J Neurooncol 95, 81–85 (2009). https://doi.org/10.1007/s11060-009-9894-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-009-9894-4